Company News
Gland Pharma Appoints Subsidiary Chief Investment Officer
Gland Pharma appoints Mr. Xiao Le as Chief Investment Officer for its Singapore subsidiary effective November 09, 2026.
Mr. Xiao Le brings 15+ years experience in healthcare investments and M&A across
